Biodexa Pharmaceuticals (BDRX) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Biodexa Pharmaceuticals has scheduled a General Meeting to propose resolutions aimed at reducing the par value of its ordinary shares, which will allow the company to issue shares above this value without altering the number of shares outstanding. This strategic move comes as the company continues to focus on developing its innovative pipeline targeting unmet medical needs, including treatments for cancer and diabetes.
For further insights into BDRX stock, check out TipRanks’ Stock Analysis page.
